PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
35.46%
Revenue growth exceeding 1.5x CSIQ's 21.55%. David Dodd would verify if faster growth reflects superior business model.
44.94%
Cost growth above 1.5x CSIQ's 18.31%. Michael Burry would check for structural cost disadvantages.
-171.55%
Gross profit decline while CSIQ shows 36.77% growth. Joel Greenblatt would examine competitive position.
-152.82%
Margin decline while CSIQ shows 12.52% expansion. Joel Greenblatt would examine competitive position.
-4.20%
R&D reduction while CSIQ shows 17.78% growth. Joel Greenblatt would examine competitive risk.
6.03%
G&A growth less than half of CSIQ's 30.61%. David Dodd would verify if efficiency advantage is structural.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.65%
Operating expenses growth while CSIQ reduces costs. John Neff would investigate differences.
38.30%
Total costs growth above 1.5x CSIQ's 14.53%. Michael Burry would check for inefficiency.
12.19%
Interest expense growth while CSIQ reduces costs. John Neff would investigate differences.
21.71%
D&A growth while CSIQ reduces D&A. John Neff would investigate differences.
-2510.65%
EBITDA decline while CSIQ shows 108.91% growth. Joel Greenblatt would examine position.
-1827.29%
EBITDA margin decline while CSIQ shows 71.88% growth. Joel Greenblatt would examine position.
-930.10%
Operating income decline while CSIQ shows 125.31% growth. Joel Greenblatt would examine position.
-660.46%
Operating margin decline while CSIQ shows 85.37% growth. Joel Greenblatt would examine position.
42.83%
Other expenses growth 1.25-1.5x CSIQ's 32.79%. Martin Whitman would scrutinize cost items.
-653.72%
Pre-tax income decline while CSIQ shows 637.29% growth. Joel Greenblatt would examine position.
-456.43%
Pre-tax margin decline while CSIQ shows 506.60% growth. Joel Greenblatt would examine position.
47.41%
Tax expense growth less than half of CSIQ's 369.42%. David Dodd would verify if advantage is sustainable.
-948.31%
Net income decline while CSIQ shows 361.91% growth. Joel Greenblatt would examine position.
-673.91%
Net margin decline while CSIQ shows 280.03% growth. Joel Greenblatt would examine position.
-946.15%
EPS decline while CSIQ shows 356.52% growth. Joel Greenblatt would examine position.
-943.59%
Diluted EPS decline while CSIQ shows 359.09% growth. Joel Greenblatt would examine position.
0.00%
Share count reduction exceeding 1.5x CSIQ's 0.16%. David Dodd would verify capital allocation.
0.07%
Diluted share reduction exceeding 1.5x CSIQ's 4.47%. David Dodd would verify capital allocation.